Medical Biomimetics Global Market Report 2024

The medical biomimetics market size has grown strongly in recent years. It will grow from $33.8 billion in 2023 to $36.6 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%. The expansion observed in the historical period can be attributed to various factors, including the increased utilization of biomimetic materials, higher research funding, a growing aging population, and an increase in the prevalence of chronic diseases. These factors collectively contributed to the development and adoption of medical biomimetics during that period.

The medical biomimetics market size is expected to see steady growth in the next few years. It will grow to $47.69 billion in 2028 at a compound annual growth rate (CAGR) of 6.8%. The anticipated growth in the forecast period is expected to be driven by factors such as the increasing demand for organ transplants, a growing awareness of biomimetics applications in healthcare, rising healthcare expenditure, the expansion of the biotechnology sector, and advancements in tissue engineering. Key trends in the forecast period encompass bio-inspired prosthetics, biomimetic sensors, applications of synthetic biology, smart drug delivery systems, biologically inspired robotics, personalized medicine, the utilization of 3D printing technologies, artificial intelligence in diagnostics, nanotechnology applications, and developments in regenerative medicine.

The anticipated rise in obesity and heart disease rates is expected to drive the growth of the medical biomimetics market. Obesity, characterized by the accumulation of excess body fat, and heart disease, encompassing various conditions affecting the heart and blood vessels, prompt the need for innovative solutions. Medical biomimetics plays a crucial role in developing assistive devices such as orthotics and prosthetics, catering to individuals managing conditions such as diabetes or obesity. In May 2022, the Centers for Disease Control and Prevention reported a significant increase in severe obesity in the US, reaching 9.2% in 2021 from 4.7%. Notably, adults aged 20 to 39 years had an obesity prevalence of 39.8%, while those aged 40 to 59 years had a prevalence of 44.3%. Additionally, a report from the UK's Office for National Statistics in March 2022 highlighted a rise in heart disease-related deaths from 19,440 in 2020 to 20,061 in 2021. The escalating rates of obesity and heart disease are therefore key drivers of the medical biomimetics market.

Leading companies in the medical biomimetics sector are strategically investing in innovative products equipped with advanced technologies. Notably, the development of a suture anchor system stands out as a significant advancement. This medical device, used in orthopedic and sports medicine procedures, secures soft tissues such as tendons or ligaments to bone. Suture anchor systems aim to mimic and enhance the natural attachment of soft tissues to bone, providing a biomechanically optimized solution mirroring physiological tissue connections. In December 2022, Stryker Corporation, a US-based multinational medical technologies company, launched Citrefix, a disposable suture anchor system incorporating a resorbable biomimetic anchor body made from Citregen, an elastomeric material engineered from a citrate polymer. This design facilitates controlled resorption without inducing chronic inflammation, making it a valuable tool in orthopedic surgical applications.

In September 2021, Keystone Dental Inc., a US-based dental implant company, strengthened its position by acquiring Osteon Medical, an Australia-based company specializing in medical biomimetics. The acquisition enables Keystone Dental to enhance its product portfolio by integrating Osteon's advanced scanning technology and cloud-based ordering platform, reinforcing its commitment to innovation in the dental implant sector.

Major companies operating in the medical biomimetics market report are BASF SE, Bayer AG, Abbott Laboratories, Stryker Corporation, Zimmer Biomet Holdings Inc., Otsuka Medical Device Company Ltd., LivaNova PLC, Össur hf., Forschungszentrum Jülich GmbH, Biohorizons Implant Systems Inc., Inventia Plc, Blatchford Limited, Keystone Dental Corporation, Xtant Medical Holdings Inc., AVINENT Science and Technology, SynTouch Inc., Curasan Inc., CorNeat Vision Inc., Hstar Technologies Co. Ltd., Veryan Medical Ltd., Swedish Biomimetics 3000 ApS, Osteopore International Pte Ltd., KitoTech Medical Ltd., Vandstrom Inc.

North America was the largest region in the medical biomimetics market in 2023. The regions covered in the medical biomimetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical biomimetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Medical biomimetics involves the creation and application of innovative technologies that mimic and enhance natural physiological processes. The goal is to develop functional and biomechanically optimized solutions in the healthcare field. Medical biomimetics plays a pivotal role in the advancement of artificial organs and tissues. Additionally, it is widely used in the design of drug delivery systems that replicate biological processes, thereby enhancing the precision and efficiency of targeted medication delivery.

The primary types of medical biomimetics encompass cardiovascular, orthopedic, ophthalmology, dental, and others. Cardiovascular medical biomimetics involves the examination and application of principles inspired by nature to create innovative solutions for medical challenges related to the heart and vascular system. These applications extend to areas such as wound healing, tissue engineering, drug delivery, and more. The end-users of cardiovascular medical biomimetics include hospitals, specialty clinics, and other healthcare facilities.

The medical biomimetics market research report is one of a series of new reports that provides medical biomimetics market statistics, including medical biomimetics industry global market size, regional shares, competitors with a medical biomimetics market share, detailed medical biomimetics market segments, market trends and opportunities, and any further data you may need to thrive in the medical biomimetics industry. This medical biomimetics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical biomimetics market consists of sales of diagnostic tools, wound healing products, bio-inspired robotics, bioelectronic devices and regenerative medicine. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values - that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.